Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates DCOY Bearish with a Setup Score of 69, net conviction 47, actionability 102. How the Setup Score works →
Total Setup Score
69
Directional Bias
Bearish
Net Conviction
47
Actionability
102 (in range)
Key signals behind this score
40wk Downtrend — falling+below (sma 6.13 vs px 1.77)
80wk Downtrend — falling+below (sma 46.75 vs px 1.77)
200wk Downtrend — falling+below (sma 727 vs px 1.77)
Short Attack — velZ +1.00 · age 12w×1.00 · 2.24%
Seasonal Headwind — october med -14.7% (mag 2/3) · posClose 36.36% (rel 1/3) · n11 ×1 = 8.8
About Decoy Therapeutics Inc.
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: January 7, 2026
Headquarters: 2450 Holcombe Blvd, Houston, TX, United States, 77021
Founder-Led: Yes — Peter Marschel (Chief Business Officer)
Key Metrics
Current Price
$1.77
Market Cap
$1.2M
Float
586K
Shares Outstanding
655K
P/E (TTM)
0.02
Price/Sales (TTM)
5.34
Operating Margin (TTM)
-1055.84%
Revenue (TTM)
$227,629
Dividend Rate
None
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$5.2M
-$7.4M
$5.2M
-$7.6M
2021
$1.8M
-$12.8M
$1.8M
-$12.7M
2022
N/A
-$31.6M
-$6,677
-$23.0M
2023
N/A
-$12.5M
-$10,051
-$12.5M
2024
N/A
-$5.6M
-$4,424
-$5.6M
2025
N/A
-$12.5M
-$8.5M
-$12.5M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
N/A
-$873,467
Dec 2025
N/A
-$9.0M
Mar 2026
N/A
-$2.2M
Jun 2026
N/A
-$2.4M
Ownership & Float
Insider Ownership
10.4%
Institutional Ownership
9.7%
Short Float
2.2%
% of All Funds Holding
0.05%
Number of Funds Holding
4
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$3.07
Near-term / short-term trend
Weekly
40-Week SMA
$6.13
Medium-term trend
Weekly
80-Week SMA
$46.75
Cyclical trend (business cycle)
Weekly
200-Week SMA
$726.64
Secular trend (multi-year)
Monthly
10-Month SMA
$5.70
Near-term monthly trend
Monthly
20-Month SMA
$45.29
Medium-term monthly trend
Monthly
40-Month SMA
$361.16
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$3.00
resistance
8.27x
0 months ago
$46.00
resistance
7.84x
10 months ago
$66.00
resistance
1.96x
12 months ago
$120.00
resistance
1.11x
13 months ago
$156.00
resistance
3.32x
14 months ago
Historical Earnings Reactions (47 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.04%
0.00%
48.94%
11.52%
-14.41%
1 Day
-2.93%
-2.90%
23.40%
22.57%
-26.60%
1 Week
-1.56%
-5.56%
29.79%
57.60%
-26.54%
2 Weeks
-0.77%
-5.10%
36.17%
57.68%
-34.57%
1 Month
0.31%
-2.68%
45.65%
108.33%
-50.19%
Next earnings: November 13, 2026 (41 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
3.2%
45.5%
11
Feb
-5.4%
33.3%
12
Mar
-1.6%
41.7%
12
Apr
-7.4%
16.7%
12
May
3.5%
58.3%
12
Jun
-5.9%
50.0%
12
Jul
-16.1%
25.0%
12
Aug
-12.4%
25.0%
12
Sep
-14.5%
8.3%
12
Oct
-12.8%
36.4%
11
Nov
-6.2%
36.4%
11
Dec
-7.2%
27.3%
11
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.07%
43.0%
549
Tuesday
-0.17%
41.9%
604
Wednesday
-0.73%
41.3%
601
Thursday
0.06%
41.8%
591
Friday
-0.33%
44.3%
587
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 9.7%
Insider Transactions — Smart Summary
Total insider ownership: 10.4%
Founder-led management: Peter Marschel (Chief Business Officer)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Decoy Therapeutics Inc.
(DCOY) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.